Kawaguchi Yohei, Mizuno Hiroko, Horikawa Mai, Kano Mayuko, Yamada Kengo, Yamakawa Fumiko, Maekawa Takashi, Yamazaki Yuto, McNamara Keely M, Sasano Hironobu, Hayashi Masayuki
Department of Endocrinology and Diabetes, Japan Community Health care Organization Chukyo Hospital.
Tohoku J Exp Med. 2017 Feb;241(2):125-129. doi: 10.1620/tjem.241.125.
Mature cystic teratoma (MCT) is rarely involved in the overproduction of steroid hormones in contrast to sex cord stromal tumors. A 31-year-old woman visited our hospital with hirsutism, hoarseness, and hair loss from the scalp. Serum testosterone and free-testosterone levels were 7.3 ng/ml and 2.3 pg/ml, respectively, which were markedly in excess of the age adjusted female standard levels. Basal blood levels of steroid hormones and serum levels of 17-hydroxyprogesterone at 1 h after intravenous injection of adrenocorticotropic hormone demonstrated that 21-hydroxylase deficiency was not the underlying cause of her virilization. A subsequent chromosomal test with G-banding revealed a karyotype of 46XX. Magnetic resonance imaging revealed a mass in the left ovary, which was subsequently diagnosed as MCT. Detailed pathological analysis of the tumor indicated that it was comprised of skin components, sweat glands, with hair and fat texture, glandular epithelium and fibrous connective tissue, consistent with the characteristic composition of MCT. Immunohistochemical analysis demonstrated marked immunoreactivity of 17beta-hydroxysteroid dehydrogenase (HSD17B5), an enzyme that can convert androstenedione to testosterone. Following surgical removal of the tumor, testosterone and free testosterone levels were markedly decreased (0.3 ng/ml and 0.4 pg/ml, respectively) and other symptoms abated. In conclusion, this is the first report of an ovarian MCT associated with clinical virilization caused by the ectopic production of testosterone possibly because of an overexpression of intratumoral HSD17B5.
与性索间质肿瘤相比,成熟囊性畸胎瘤(MCT)很少导致甾体激素分泌过多。一名31岁女性因多毛、声音嘶哑和头皮脱发前来我院就诊。血清睾酮和游离睾酮水平分别为7.3 ng/ml和2.3 pg/ml,明显高于年龄校正后的女性标准水平。静脉注射促肾上腺皮质激素1小时后的甾体激素基础血水平和17-羟孕酮血清水平显示,21-羟化酶缺乏不是其男性化的根本原因。随后的G带染色体检测显示核型为46XX。磁共振成像显示左卵巢有一个肿块,随后被诊断为MCT。对肿瘤进行详细的病理分析表明,它由皮肤成分、汗腺、毛发和脂肪组织、腺上皮和纤维结缔组织组成,与MCT的特征性组成一致。免疫组织化学分析显示17β-羟类固醇脱氢酶(HSD17B5)有明显的免疫反应性,该酶可将雄烯二酮转化为睾酮。手术切除肿瘤后,睾酮和游离睾酮水平显著下降(分别为0.3 ng/ml和0.4 pg/ml),其他症状也有所缓解。总之,这是首例因肿瘤内HSD17B5过表达导致睾酮异位产生而引起临床男性化的卵巢MCT报告。